Successful Imatinib Treatment of an Abdominal Compartment Syndrome due to Huge Gastrointestinal Stromal Tumour

Gastrointestinal stromal tumours (GISTs) are the most common digestive mesenchymal tumours, whose prognosis has been revolutionised by targeted therapies such as oral imatinib. Abdomen compartment syndrome (ACS) is associated with mortality superior to 50% in adults. ACS has never been reported to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertucci, Alexandre, Guiramand, Jérôme, Mescam, Lena, Monneur, Audrey, Bisbal, Magali, Chow-Chine, Laurent, Sannini, Antoine, Perrot, Delphine, De Luca, Valéria, Mokart, Djamel, Bertucci, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751450/
https://www.ncbi.nlm.nih.gov/pubmed/31572153
http://dx.doi.org/10.1159/000502338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751450/
https://www.ncbi.nlm.nih.gov/pubmed/31572153
http://dx.doi.org/10.1159/000502338

Ejemplares similares